Literature DB >> 31099564

Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFASs) and Association between the Placental Transfer Efficiencies and Dissociation Constant of Serum Proteins-PFAS Complexes.

Ke Gao1,2, Taifeng Zhuang3, Xian Liu1, Jianjie Fu1, Jingxing Zhang1,4, Jie Fu1,2, Liguo Wang1,2, Aiqian Zhang1,2,4, Yong Liang4, Maoyong Song1, Guibin Jiang1,2.   

Abstract

Information on placental transfer and adverse outcomes of short-chain per- and polyfluoroalkyl substance (PFASs) is limited, and factors responsible for PFAS placental transfer are still unclear. In the present study, concentrations of 21 PFASs were analyzed in 132 paired maternal and cord serum samples collected from residents in Beijing, China, and the placental transfer efficiency (PTE) of each PFAS was calculated. PTEs of short-chain perfluoroalkyl acids (PFAAs), including PFBA (146%), PFBS (97%), PFPeA (118%), and PFHxA (110%), were first reported, and a complete U-shaped trend of PTEs from C4 to C13 of perfluoroalkyl carboxylic acids (PFCAs) was obtained. Positive association between maternal weight and PTE of perfluorooctanesulfonate (PFOS) ( p < 0.05) and negative association between maternal PFBA concentration and birth length ( p < 0.01) were observed. Using in vitro experiments, we further determined equilibrium dissociation constants ( Kds) of human serum albumin (HSA)-PFAS complexes ( Kd-HP), serum proteins-PFAS complexes ( Kd-SP), and liver-fatty acid binding protein (L-FABP)-PFAS complexes ( Kd-LP) and found that they were all significantly correlated with PTEs of PFASs. The correlation coefficient was 0.92, 0.89, and 0.86, respectively ( p < 0.01 in all three tests), suggesting that Kds of protein (serum)-PFAS complexes can play an important role in trans-placental transfer of PFASs in human and Kd-HP plays a pivotal role.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31099564     DOI: 10.1021/acs.est.9b00715

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  11 in total

1.  Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.

Authors:  Samantha M Hall; Sharon Zhang; Kate Hoffman; Marie Lynn Miranda; Heather M Stapleton
Journal:  Chemosphere       Date:  2022-02-07       Impact factor: 7.086

2.  Modeling the transplacental transfer of small molecules using machine learning: a case study on per- and polyfluorinated substances (PFAS).

Authors:  Dimitri Abrahamsson; Adi Siddharth; Joshua F Robinson; Anatoly Soshilov; Sarah Elmore; Vincent Cogliano; Carla Ng; Elaine Khan; Randolph Ashton; Weihsueh A Chiu; Jennifer Fung; Lauren Zeise; Tracey J Woodruff
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-10-07       Impact factor: 6.371

3.  Nontarget Screening of Per- and Polyfluoroalkyl Substances Binding to Human Liver Fatty Acid Binding Protein.

Authors:  Diwen Yang; Jiajun Han; David Ross Hall; Jianxian Sun; Jesse Fu; Steven Kutarna; Keith A Houck; Carlie A LaLone; Jon A Doering; Carla A Ng; Hui Peng
Journal:  Environ Sci Technol       Date:  2020-04-16       Impact factor: 9.028

4.  Dominant entropic binding of perfluoroalkyl substances (PFASs) to albumin protein revealed by 19F NMR.

Authors:  Michael Fedorenko; Jessica Alesio; Anatoliy Fedorenko; Angela Slitt; Geoffrey D Bothun
Journal:  Chemosphere       Date:  2020-09-02       Impact factor: 7.086

5.  The Nrf2a pathway impacts zebrafish offspring development with maternal preconception exposure to perfluorobutanesulfonic acid.

Authors:  Kate M Annunziato; Marjorie Marin; Wenle Liang; Sarah M Conlin; Weipeng Qi; Jeffery Doherty; Jonghwa Lee; John M Clark; Yeonhwa Park; Alicia R Timme-Laragy
Journal:  Chemosphere       Date:  2021-09-02       Impact factor: 7.086

6.  Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Umbilical Cord Blood DNA Methylation, and Cardio-Metabolic Indicators in Newborns: The Healthy Start Study.

Authors:  Anne P Starling; Cuining Liu; Guannan Shen; Ivana V Yang; Katerina Kechris; Sarah J Borengasser; Kristen E Boyle; Weiming Zhang; Harry A Smith; Antonia M Calafat; Richard F Hamman; John L Adgate; Dana Dabelea
Journal:  Environ Health Perspect       Date:  2020-12-24       Impact factor: 9.031

7.  Sulfonamide functional head on short-chain perfluorinated substance drives developmental toxicity.

Authors:  Yvonne Rericha; Dunping Cao; Lisa Truong; Michael T Simonich; Jennifer A Field; Robyn L Tanguay
Journal:  iScience       Date:  2022-01-18

8.  Inactivation of common airborne antigens by perfluoroalkyl chemicals modulates early life allergic asthma.

Authors:  Mengjing Wang; Qianqian Li; Meifang Hou; Louisa L Y Chan; Meng Liu; Soo Kai Ter; Ting Dong; Yun Xia; Sanjay H Chotirmall; Mingliang Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

Review 9.  Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances.

Authors:  Alexis M Temkin; Barbara A Hocevar; David Q Andrews; Olga V Naidenko; Lisa M Kamendulis
Journal:  Int J Environ Res Public Health       Date:  2020-03-04       Impact factor: 3.390

10.  Exposure to Perfluoroalkyl Substances During Pregnancy and Fetal BDNF Level: A Prospective Cohort Study.

Authors:  Guoqi Yu; Fei Luo; Min Nian; Shuman Li; Bin Liu; Liping Feng; Jun Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.